Enlaza Therapeutics
Enlaza Therapeutics is a clinical-stage biopharmaceutical company in La Jolla, California developing first-in-class covalent protein biologics for cancer and other serious diseases. Its proprietary War-Lock technology uses engineered unnatural amino acids to enable protein drugs — including antibody-drug conjugates and T-cell engagers — to bind their disease targets irreversibly, aiming for sustained target occupancy and a prolonged biologic effect with minimal systemic exposure across oncology and immuno-oncology applications. The company was surfaced as a portfolio company of Lightspeed Venture Partners and added to the API Evangelist network; it publishes a corporate website but no public developer API surface.
Enlaza Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Therapeutics, and Oncology.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API